Study Conduct

ACRES, Ethical to collaborate on eAdjudication

Wednesday, November 25, 2015

Basel, Switzerland-based Ethical, a provider of Centralized Endpoint Adjudication solutions for clinical trials, and Cambridge, Mass.-based Alliance for Clinical Research Excellence and Safety (ACRES) , a multi-sector nonprofit organization building a multi-stakeholder-driven integrated global system for clinical research, have partnered to improve Centralized Endpoint Adjudication—an essential element of drug development.

[Read More]

Parexel, Kyoto ink agreement for Japan’s biopharmaceutical workforce

Friday, November 13, 2015

Parexel International, a global biopharmaceutical services provider, and Kyoto Pharmaceutical University (KPU), a private pharmacy and science university, have announced a new joint program for clinical research and clinical trial management. The academic program offers undergraduate students an accredited, seven-week course designed to prepare them for careers in the biopharmaceutical industry.

[Read More]

Biosimilars legislation approved in New Jersey

Wednesday, November 11, 2015

Legislation sponsored by Assembly Democrats of the New Jersey General Assembly (Pamela Lampitt, Daniel Benson, Shavonda Sumter, Nancy Pinkin, and Herb Conaway Jr., M.D.) to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer has been signed into law.

[Read More]

SCRS adds Icon as global impact partner

Monday, November 9, 2015

The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites, has announced a two-year relationship with Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. Icon will participate as a global impact partner (GIP) and align with 31 other sponsors, CROs and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

[Read More]